EirGenix Revenue

Biotechnology Research • 101, Lane 169, Taiwan, Province of China • 201-500 Employees

EirGenix revenue & valuation

Annual revenue	$50,300,000
Revenue per employee	$217,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$161,000,000
Total funding	No funding

Key Contacts at EirGenix

Cj Chang

Ceo Of Biomanufacturing Bu

Lee-Cheng Liu

Founder, President & Ceo

Albert Chung-Huan Lin

Business Development Director

Judy Liu

Human Resources_Executive Affairs_Administration Director

Bryan Wu

Senior Director, Process Science

Hark Chen

Executive Director, Manufacturing Technology And Operation

Ann Lin

Associate Director

Victor Lee

R&D Director

Georg Schöndorfer

Medical Director At Eirgenix Europe Gmbh.

Ching-Hui Yang

Associate Director

Company overview

Headquarters	101, Lane 169, Kangning St., Xizhi Dist,, New Taipei City, 22180, TW
Phone number	+886277080123
Website	eirgenix.com
NAICS	541714
SIC	873
Founded	2012
Employees	201-500
Socials

EirGenix Email Formats

EirGenix uses 5 email formats. The most common is {first name} (e.g., john@eirgenix.com), used 29.4% of the time.

Format	Example	Percentage
{first name}	john@eirgenix.com	29.4%
{first initial}.{last name}	j.doe@eirgenix.com	23.5%
{first name}{last name}	johndoe@eirgenix.com	23.5%
{first initial}{last name}	jdoe@eirgenix.com	17.6%
{first name}.{last name}	john.doe@eirgenix.com	5.9%

About EirGenix

EirGenix is a contract development and manufacturing organization that provides high-quality and cost-effective service. We support our clients in the development, analytical testing, and cGMP manufacturing of biopharmaceuticals from pre-clinical to commercial manufacturing. EirGenix also specializes in the development of biologics, specializing in the development of biosimilars. Our Services: - Cell Line Development (mammalian/microbial systems) - Process Development and Process Optimization - Analytical Services and Quality Control - cGMP Manufacturing (mammalian/microbial systems) - Taiwan FDA inspected/approved - Japan PMDA inspected/approved - U.S. FDA inspection pending (June 2022) - EMA inspection pending (2022-2023) - Antibody-Drug Conjugate (ADC) Development and Manufacturing

Employees by Management Level

Total employees: 201-500

Seniority

Employees

Entry

Manager

Director

Employees by Department

EirGenix has 68 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore EirGenix's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-09-15	14	N/A

Funding Insights

Number of funding rounds

EirGenix Tech Stack

Discover the technologies and tools that power EirGenix's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Goober

JavaScript libraries

Microsoft 365

jQuery

JavaScript libraries

HubSpot Analytics

Analytics

HTTP/3

Miscellaneous

HSTS

Security

Google Analytics

Analytics

YouTube

Video players

Bootstrap

UI frameworks

Google Tag Manager

Tag managers

React

JavaScript frameworks

Frequently asked questions

EirGenix is located in 101, Lane 169, TW.

You can reach EirGenix at +886277080123.

EirGenix generates an estimated annual revenue of $50,297,416. This revenue figure reflects the company's market position and business performance in its industry.

EirGenix has an estimated valuation of $161,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

EirGenix was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

EirGenix has approximately 201-500 employees. The company continues to grow its workforce to support its business operations and expansion.